Search hospitals > Massachusetts > Boston
Massachusetts General Hospital
Claim this profileBoston, Massachusetts 02114
Global Leader in Breast Cancer
Global Leader in Cancer
Conducts research for Tumors
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Lung Cancer
4192 reported clinical trials
362 medical researchers
Summary
Massachusetts General Hospital is a medical facility located in Boston, Massachusetts. This center is recognized for care of Breast Cancer, Cancer, Tumors, Non-Small Cell Lung Cancer, Lung Cancer and other specialties. Massachusetts General Hospital is involved with conducting 4,192 clinical trials across 2,329 conditions. There are 362 research doctors associated with this hospital, such as David M. King, Sabine s Coppieters, MD, Ryan Sullivan, MD, and Gregory Cote, MD.Area of expertise
1Breast Cancer
Global LeaderStage IV
Stage III
HER2 negative
2Cancer
Global LeaderStage IV
Stage III
EGFR positive
Top PIs
David M. KingPark Nicollet Clinic - Saint Louis Park7 years of reported clinical research
Expert in Cancer
Expert in Lung Cancer
97 reported clinical trials
159 drugs studied
Sabine s Coppieters, MDInvestigator site 2 - US00100872 years of reported clinical research
Studies Myasthenia Gravis
Studies Muscle Weakness
25 reported clinical trials
13 drugs studied
Ryan Sullivan, MDMassachusetts General Hospital3 years of reported clinical research
Expert in Melanoma
Studies Solid Tumors
21 reported clinical trials
34 drugs studied
Gregory Cote, MDMassachusetts General Hospital5 years of reported clinical research
Studies Sarcoma
Studies Solid Tumors
19 reported clinical trials
27 drugs studied
Clinical Trials running at Massachusetts General Hospital
Breast Cancer
Depression
Multiple Myeloma
Plasma Cell Neoplasms
Autism Spectrum Disorder
Autism
Acute Myeloid Leukemia
Interstitial Lung Disease
Tumors
Multiple Sclerosis
Sacituzumab Govitecan
for Triple-Negative Breast Cancer
This trial is testing a drug called sacituzumab govitecan-hziy, which targets and kills cancer cells. It focuses on patients with advanced triple-negative breast cancer who have limited treatment options. The drug works by attaching to cancer cells and releasing a substance that kills them. Sacituzumab govitecan-hziy is an FDA-approved treatment for metastatic triple-negative breast cancer, especially for patients who have already tried other treatments.
Recruiting4 awards Phase 3
Sacituzumab Govitecan + Pembrolizumab
for Triple-Negative Breast Cancer
This trial compares the effectiveness of a combination of two drugs, SG and pembrolizumab, in patients with advanced triple-negative breast cancer. SG targets and kills cancer cells with chemotherapy, while pembrolizumab helps the immune system attack the cancer. Pembrolizumab has been shown to improve survival in various cancers, including triple-negative breast cancer, when used alone or in combination with other treatments.
Recruiting4 awards Phase 3
CDK 4/6 Inhibitor + Endocrine Therapy
for Breast Cancer
This research study is studying a drug as a possible treatment for ER-positive Breast Cancer The drug involved in this study is: -Ribociclib
Recruiting3 awards Phase 216 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Massachusetts General Hospital?
Massachusetts General Hospital is a medical facility located in Boston, Massachusetts. This center is recognized for care of Breast Cancer, Cancer, Tumors, Non-Small Cell Lung Cancer, Lung Cancer and other specialties. Massachusetts General Hospital is involved with conducting 4,192 clinical trials across 2,329 conditions. There are 362 research doctors associated with this hospital, such as David M. King, Sabine s Coppieters, MD, Ryan Sullivan, MD, and Gregory Cote, MD.
Where is Massachusetts General Hospital located?
**Massachusetts General Hospital Location and Directions:**
- **Address:** 55 Fruit St, Boston, Massachusetts.
- **Directions via Route 1 South:** Continue on Route 1 South, turn right onto Storrow Drive east, follow to the Government Center exit, turn left onto Cambridge Street, then left onto North Grove Street. The main entrance and emergency room are at the end of North Grove Street.
- **Public Transportation:** The Spaulding Express shuttle runs approximately every 10 minutes from North Station, stopping at Haverhill Street at the corner of Causeway Street, across from the TD Garden.
Who should I call to ask about financial aid or insurance network?
**Massachusetts General Hospital Financial Assistance & Insurance Information:**
- For assistance with financial matters or insurance, contact Patient Financial Services at (617) 726-3884.
- For information on accepted health insurance plans, please refer to the hospital's website.
- Assistance with understanding medical bills or setting up payment plans is available through a patient financial counselor at the hospital or health center.
What insurance does Massachusetts General Hospital accept?
Massachusetts General Hospital accepts a wide range of insurance plans, including but not limited to Aetna, AllWays Health Partners, Blue Cross Blue Shield of Massachusetts, BMC HealthNet MassHealth MCO Plan, Cigna, Coventry, Fallon Health, Harvard Pilgrim Health Care, Humana, MultiPlan/Private Healthcare Systems, Senior Whole Health, Stride Medicare Replacement, Tufts Health Plan, and UniCare. It is essential to check with your health insurance provider to understand your specific coverage and potential costs before scheduling your visit. Please note, additional referrals or authorizations may be required for some services, and coverage may vary by location.
What awards or recognition has Massachusetts General Hospital received?
Massachusetts General Hospital (MGH) in Boston, Massachusetts, boasts the largest hospital-based research program in the United States, with a 2021 budget of nearly $1.2 billion. It ranks first among independent hospitals for annual funding from the National Institutes of Health (NIH) and eighth among all institutions. MGH's research infrastructure includes 30 departments, centers, and institutes, over 9,500 personnel, and spans 1.3 million square feet across Boston, Cambridge, and Charlestown.